Johnson & Johnson (NYSE:JNJ) today announced plans to launch a new module as part of its cardiac mapping platform.
Researchers at the University of São Paulo (USP) in Brazil discovered that neurodegenerative diseases, such as Alzheimer's, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results